BDBM536425 (S)-5-(1-(2-((5-chloro-2- (2,4-dimethylpiperazin-1- yl)pyridin-4-yl)amino)-2- oxoethyl)-4-oxo-4,6,7,8- tetrahydro-1H-dipyrrolo [1,2-a:2',3'-d]pyrimidin- 3-yl)-3,4-difluoro-2- hydroxybenzamide::US11242351, Compound I-4

SMILES C[C@H]1CN(C)CCN1c1cc(NC(=O)Cn2cc(-c3cc(C(N)=O)c(O)c(F)c3F)c3c2nc2CCCn2c3=O)c(Cl)cn1

InChI Key InChIKey=UPWACBOVNACRFH-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536425   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536425((S)-5-(1-(2-((5-chloro-2- (2,4-dimethylpiperazin-1...)
Affinity DataKd:  23.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent